Table 2.

Adverse events considered related to BI 836826 occurring in > 2 patients

	Any-grade n (%)	Grade 3/4 n (%)
Infusion-related reactions	4 (67)	1 (17)
Neutropenia	3 (50)	2 (33)
Anemia	2 (33)	2 (33)
Lymphopenia	2 (33)	2 (33)
Fatigue	2 (33)	0